These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 12907021)
1. New generation versus conventional antipsychotics. Geddes J; Harrison P; Freemantle N Lancet; 2003 Aug; 362(9381):404; author reply 404-5. PubMed ID: 12907021 [No Abstract] [Full Text] [Related]
2. Subjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent doses. Tandon R; Nasrallah HA Arch Gen Psychiatry; 2006 Aug; 63(8):935-7; author reply 937-9. PubMed ID: 16894070 [No Abstract] [Full Text] [Related]
3. First- and second-generation antipsychotics: learning from CUtLASS and CATIE. Tandon R; Carpenter WT; Davis JM Arch Gen Psychiatry; 2007 Aug; 64(8):977-8; author reply 979-80. PubMed ID: 17679642 [No Abstract] [Full Text] [Related]
4. A meta-analysis of the efficacy of second-generation antipsychotics. Davis JM; Chen N; Glick ID Arch Gen Psychiatry; 2003 Jun; 60(6):553-64. PubMed ID: 12796218 [TBL] [Abstract][Full Text] [Related]
9. Are new drugs for schizophrenia better than old ones? Gøtzsche P Lancet; 2009 Apr; 373(9671):1248; author reply 1249-50. PubMed ID: 19362667 [No Abstract] [Full Text] [Related]
10. Efficacy and effectiveness of first- and second-generation antipsychotics in schizophrenia. Jaffe AB; Levine J J Clin Psychiatry; 2003; 64 Suppl 17():3-6. PubMed ID: 14680419 [TBL] [Abstract][Full Text] [Related]
11. [Antipsychotic drug combinations in the treatment of schizophrenia. A review of the literature]. Gazdag G; Tolna J; Bitter I Neuropsychopharmacol Hung; 2012 Sep; 14(3):189-95. PubMed ID: 22987732 [TBL] [Abstract][Full Text] [Related]
12. [Antipsychotic agents: what do meta analyses say?]. Millet B Encephale; 2007 Jun; 33 Pt 3():S419-24. PubMed ID: 19101363 [No Abstract] [Full Text] [Related]
13. First- vs second-generation antipsychotic drugs in schizophrenia. Andrade C; Kharawala S Arch Gen Psychiatry; 2007 Aug; 64(8):978-9; author reply 979-80. PubMed ID: 17679643 [No Abstract] [Full Text] [Related]
14. [Priority for atypical antipsychotic drugs? Current studies clarify the issues]. Dose M Psychiatr Prax; 2007 Jan; 34(1):46-9. PubMed ID: 17265252 [No Abstract] [Full Text] [Related]
15. Pharmacological treatment of schizophrenia. Leucht S; Heres S; Kissling W; Davis JM Fortschr Neurol Psychiatr; 2013 May; 81(5):e1-13. PubMed ID: 23702802 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic treatment of adolescent and child schizophrenia. Young CM; Findling RL Expert Rev Neurother; 2004 Jan; 4(1):53-60. PubMed ID: 15853615 [TBL] [Abstract][Full Text] [Related]
17. Treatment of schizophrenia patients: comparing new-generation antipsychotics to each other. Fleischhacker WW; Widschwendter CG Curr Opin Psychiatry; 2006 Mar; 19(2):128-34. PubMed ID: 16612191 [TBL] [Abstract][Full Text] [Related]
19. Review of treatments that can ameliorate nonadherence in patients with schizophrenia. Kane JM J Clin Psychiatry; 2006; 67 Suppl 5():9-14. PubMed ID: 16822091 [TBL] [Abstract][Full Text] [Related]